Arch Therapeutics
Natick
About Arch Therapeutics
Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $27.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2023)
- Ticker: otcqb:ARTH
- Website: archtherapeutics.com
- Phone: 1 617.475.5254
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/arch-therapeutics-183132 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.